Delhi High Court restrains generic pharmaceutical companies from making Novartis patented drug
JURIST
NOVEMBER 3, 2021
The Delhi High Court Tuesday issued an injunction against various generic pharmaceutical companies, preventing them from manufacturing or selling Valsartan and Sacubitril tablets used to treat cardiovascular diseases. These all are generic pharmaceutical companies manufacturing or selling Valsartan and Sacubitril.
Let's personalize your content